Advanced company searchLink opens in new window

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

Company number 02486738

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Mar 2023 GAZ2(A) Final Gazette dissolved via voluntary strike-off
03 Jan 2023 GAZ1(A) First Gazette notice for voluntary strike-off
22 Dec 2022 DS01 Application to strike the company off the register
10 Nov 2022 TM01 Termination of appointment of Mark Gibbons as a director on 8 November 2022
04 Jul 2022 CS01 Confirmation statement made on 28 June 2022 with updates
19 May 2022 AA Full accounts made up to 31 March 2021
21 Mar 2022 AP01 Appointment of Peter Michael Grubin as a director on 1 March 2022
21 Mar 2022 TM01 Termination of appointment of Kentaro Shirahata as a director on 1 March 2022
11 Nov 2021 SH19 Statement of capital on 11 November 2021
  • GBP 1
11 Nov 2021 SH20 Statement by Directors
11 Nov 2021 CAP-SS Solvency Statement dated 09/11/21
11 Nov 2021 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
09 Jul 2021 CS01 Confirmation statement made on 28 June 2021 with no updates
17 Apr 2021 AA Full accounts made up to 31 March 2020
01 Dec 2020 AP01 Appointment of Mr Mark Gibbons as a director on 30 November 2020
01 Dec 2020 AP01 Appointment of Mr Marc Stuart Page as a director on 30 November 2020
01 Dec 2020 TM01 Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020
01 Dec 2020 TM01 Termination of appointment of Sarah Lucy Charsley as a director on 30 November 2020
02 Jul 2020 CS01 Confirmation statement made on 28 June 2020 with no updates
28 Apr 2020 CH04 Secretary's details changed for Shire Corporate Services Limited on 28 April 2020
04 Mar 2020 AA01 Current accounting period extended from 31 December 2019 to 31 March 2020
05 Dec 2019 AUD Auditor's resignation
10 Oct 2019 AA Full accounts made up to 31 December 2018
10 Jul 2019 CS01 Confirmation statement made on 28 June 2019 with no updates
04 Mar 2019 AP01 Appointment of Mr Nicholas Hugh Meryon Insall as a director on 28 February 2019